Respiratory Syncytial Virus (RSV) Diagnostics Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Respiratory Syncytial Virus (RSV) Diagnostics in Global, including the following market information:
Global Respiratory Syncytial Virus (RSV) Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Respiratory Syncytial Virus (RSV) Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Molecular Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Respiratory Syncytial Virus (RSV) Diagnostics include Roche, AstraZeneca, Merck, AbbVie, Bausch Health, GlaxoSmithKline, ReViral, Gilead Sciences and Teva Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Respiratory Syncytial Virus (RSV) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Respiratory Syncytial Virus (RSV) Diagnostics Market Segment Percentages, by Type, 2021 (%)
Global Respiratory Syncytial Virus (RSV) Diagnostics Market Segment Percentages, by Application, 2021 (%)
Global Respiratory Syncytial Virus (RSV) Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Respiratory Syncytial Virus (RSV) Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Respiratory Syncytial Virus (RSV) Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Respiratory Syncytial Virus (RSV) Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Respiratory Syncytial Virus (RSV) Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Molecular Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Respiratory Syncytial Virus (RSV) Diagnostics include Roche, AstraZeneca, Merck, AbbVie, Bausch Health, GlaxoSmithKline, ReViral, Gilead Sciences and Teva Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Respiratory Syncytial Virus (RSV) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Respiratory Syncytial Virus (RSV) Diagnostics Market Segment Percentages, by Type, 2021 (%)
- Molecular Diagnosis
- Rapid Antigen Testing
- Other
Global Respiratory Syncytial Virus (RSV) Diagnostics Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinic
- Laborary
- Other
Global Respiratory Syncytial Virus (RSV) Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Respiratory Syncytial Virus (RSV) Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Respiratory Syncytial Virus (RSV) Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- AstraZeneca
- Merck
- AbbVie
- Bausch Health
- GlaxoSmithKline
- ReViral
- Gilead Sciences
- Teva Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Respiratory Syncytial Virus (RSV) Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL RESPIRATORY SYNCYTIAL VIRUS (RSV) DIAGNOSTICS OVERALL MARKET SIZE
2.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size: 2021 VS 2028
2.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Respiratory Syncytial Virus (RSV) Diagnostics Players in Global Market
3.2 Top Global Respiratory Syncytial Virus (RSV) Diagnostics Companies Ranked by Revenue
3.3 Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Syncytial Virus (RSV) Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Respiratory Syncytial Virus (RSV) Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Syncytial Virus (RSV) Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Respiratory Syncytial Virus (RSV) Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Respiratory Syncytial Virus (RSV) Diagnostics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Molecular Diagnosis
4.1.3 Rapid Antigen Testing
4.1.4 Other
4.2 By Type - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Laborary
5.1.5 Other
5.2 By Application - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2028
6.3.2 US Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.3.3 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.3.4 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2028
6.4.2 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4.3 France Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4.4 U.K. Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4.5 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4.6 Russia Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4.8 Benelux Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2028
6.5.2 China Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.5.3 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.5.4 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.5.6 India Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2028
6.6.2 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.6.3 Argentina Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2028
6.7.2 Turkey Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.7.3 Israel Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.7.5 UAE Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.1.4 Roche Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.2.4 AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.3.4 Merck Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Merck Key News
7.4 AbbVie
7.4.1 AbbVie Corporate Summary
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.4.4 AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.4.5 AbbVie Key News
7.5 Bausch Health
7.5.1 Bausch Health Corporate Summary
7.5.2 Bausch Health Business Overview
7.5.3 Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.5.4 Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.5.5 Bausch Health Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.6.4 GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline Key News
7.7 ReViral
7.7.1 ReViral Corporate Summary
7.7.2 ReViral Business Overview
7.7.3 ReViral Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.7.4 ReViral Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.7.5 ReViral Key News
7.8 Gilead Sciences
7.8.1 Gilead Sciences Corporate Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.8.4 Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.8.5 Gilead Sciences Key News
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Corporate Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.9.4 Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.9.5 Teva Pharmaceutical Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Respiratory Syncytial Virus (RSV) Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL RESPIRATORY SYNCYTIAL VIRUS (RSV) DIAGNOSTICS OVERALL MARKET SIZE
2.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size: 2021 VS 2028
2.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Respiratory Syncytial Virus (RSV) Diagnostics Players in Global Market
3.2 Top Global Respiratory Syncytial Virus (RSV) Diagnostics Companies Ranked by Revenue
3.3 Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Syncytial Virus (RSV) Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Respiratory Syncytial Virus (RSV) Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Syncytial Virus (RSV) Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Respiratory Syncytial Virus (RSV) Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Respiratory Syncytial Virus (RSV) Diagnostics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Molecular Diagnosis
4.1.3 Rapid Antigen Testing
4.1.4 Other
4.2 By Type - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Laborary
5.1.5 Other
5.2 By Application - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2028
6.3.2 US Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.3.3 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.3.4 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2028
6.4.2 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4.3 France Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4.4 U.K. Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4.5 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4.6 Russia Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.4.8 Benelux Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2028
6.5.2 China Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.5.3 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.5.4 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.5.6 India Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2028
6.6.2 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.6.3 Argentina Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2028
6.7.2 Turkey Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.7.3 Israel Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
6.7.5 UAE Respiratory Syncytial Virus (RSV) Diagnostics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.1.4 Roche Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.2.4 AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.3.4 Merck Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Merck Key News
7.4 AbbVie
7.4.1 AbbVie Corporate Summary
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.4.4 AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.4.5 AbbVie Key News
7.5 Bausch Health
7.5.1 Bausch Health Corporate Summary
7.5.2 Bausch Health Business Overview
7.5.3 Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.5.4 Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.5.5 Bausch Health Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.6.4 GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline Key News
7.7 ReViral
7.7.1 ReViral Corporate Summary
7.7.2 ReViral Business Overview
7.7.3 ReViral Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.7.4 ReViral Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.7.5 ReViral Key News
7.8 Gilead Sciences
7.8.1 Gilead Sciences Corporate Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.8.4 Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.8.5 Gilead Sciences Key News
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Corporate Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Major Product Offerings
7.9.4 Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global Market (2017-2022)
7.9.5 Teva Pharmaceutical Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Respiratory Syncytial Virus (RSV) Diagnostics Market Opportunities & Trends in Global Market
Table 2. Respiratory Syncytial Virus (RSV) Diagnostics Market Drivers in Global Market
Table 3. Respiratory Syncytial Virus (RSV) Diagnostics Market Restraints in Global Market
Table 4. Key Players of Respiratory Syncytial Virus (RSV) Diagnostics in Global Market
Table 5. Top Respiratory Syncytial Virus (RSV) Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Respiratory Syncytial Virus (RSV) Diagnostics Product Type
Table 9. List of Global Tier 1 Respiratory Syncytial Virus (RSV) Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Respiratory Syncytial Virus (RSV) Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 32. Roche Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 35. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 38. Merck Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. AbbVie Corporate Summary
Table 40. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 41. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Bausch Health Corporate Summary
Table 43. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 44. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 47. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. ReViral Corporate Summary
Table 49. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 50. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Gilead Sciences Corporate Summary
Table 52. Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 53. Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Teva Pharmaceutical Corporate Summary
Table 55. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 56. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 1. Respiratory Syncytial Virus (RSV) Diagnostics Market Opportunities & Trends in Global Market
Table 2. Respiratory Syncytial Virus (RSV) Diagnostics Market Drivers in Global Market
Table 3. Respiratory Syncytial Virus (RSV) Diagnostics Market Restraints in Global Market
Table 4. Key Players of Respiratory Syncytial Virus (RSV) Diagnostics in Global Market
Table 5. Top Respiratory Syncytial Virus (RSV) Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Respiratory Syncytial Virus (RSV) Diagnostics Product Type
Table 9. List of Global Tier 1 Respiratory Syncytial Virus (RSV) Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Respiratory Syncytial Virus (RSV) Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Respiratory Syncytial Virus (RSV) Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 32. Roche Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 35. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 38. Merck Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. AbbVie Corporate Summary
Table 40. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 41. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Bausch Health Corporate Summary
Table 43. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 44. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 47. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. ReViral Corporate Summary
Table 49. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 50. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Gilead Sciences Corporate Summary
Table 52. Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 53. Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Teva Pharmaceutical Corporate Summary
Table 55. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Product Offerings
Table 56. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Respiratory Syncytial Virus (RSV) Diagnostics Segment by Type in 2021
Figure 2. Respiratory Syncytial Virus (RSV) Diagnostics Segment by Application in 2021
Figure 3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Respiratory Syncytial Virus (RSV) Diagnostics Revenue in 2021
Figure 8. By Type - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Respiratory Syncytial Virus (RSV) Diagnostics Segment by Type in 2021
Figure 2. Respiratory Syncytial Virus (RSV) Diagnostics Segment by Application in 2021
Figure 3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Respiratory Syncytial Virus (RSV) Diagnostics Revenue in 2021
Figure 8. By Type - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Respiratory Syncytial Virus (RSV) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
